A Phase II, Single-Center, Randomized, Double-Blind, Assessment of the Abuse Liability of Acurox (oxycodone HCl and niacin) Tablets in Subjects with a History of Opioid Abuse
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2008
At a glance
- Drugs Niacin; Oxycodone; Oxycodone/niacin
- Indications Drug abuse; Pain
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Acura Pharmaceuticals
- 22 Oct 2008 Status changed from planning to completed, as reported by clinicaltrials.gov.
- 13 Oct 2008 Top-line results have been reported by Acura Pharmaceuticals in a media release.
- 05 Mar 2008 New trial record.